13.12
Amneal Pharmaceuticals Inc Aktie (AMRX) Neueste Nachrichten
Is AMRX stock undervalued? Sales multiple, target, upside - MSN
Amneal Launches First Two Respiratory Metered-Dose Inhalation Products in the U.S. - Yahoo! Finance Canada
Amneal launches generic bimatoprost 0.01% to US market - Eyes On Eyecare
AMRX: 3 growth drivers behind Amneal's 2026 outlook - MSN
Here's how AMRX is tapping GLP-1 demand through manufacturing - MSN
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced the official launch of Albuterol Sulfate and Beclomethasone Dipropionate HFA inhalation aerosols in the U.S. market. - Bitget
Institution Moves: Is Amneal Pharmaceuticals Inc a strong candidate for buy and hold2026 Price Momentum & Low Risk High Reward Ideas - baoquankhu1.vn
Aug Fed Impact: Is Amneal Pharmaceuticals Inc in a long term uptrend2026 Volatility Report & Long Hold Capital Preservation Tips - baoquankhu1.vn
Should Amneal’s New Generic Glaucoma Launch Shape How AMRX Investors View Its Specialty Strategy? - Sahm
Fund Flows: Is Amneal Pharmaceuticals Inc forming a double bottomEarnings Overview Summary & Fast Momentum Entry Tips - baoquankhu1.vn
AMRX: 3 Growth Drivers Behind Amneal's 2026 Outlook - qz.com
Here's How AMRX Is Tapping GLP-1 Demand Through Manufacturing - qz.com
Is AMRX Stock Undervalued? Sales Multiple, Target, Upside - qz.com
Why Amneal Pharmaceuticals (AMRX) is a top growth stock for the long term - MSN
AMRX: 3 Key Factors Fueling Amneal's Projections for 2026 - Bitget
Here's the way AMRX is leveraging the demand for GLP-1 via its manufacturing operations - Bitget
Why Amneal Pharmaceuticals (AMRX) Stands Out as a Leading Long-Term Growth Stock - Bitget
Why Amneal Pharmaceuticals (AMRX) is a Top Growth Stock for the Long-Term - Yahoo Finance
FOCUS-Patients scramble to find estrogen patches as shortage worsens after US FDA champions use - Sahm
Is It Time To Reassess Amneal Pharmaceuticals (AMRX) After Its Strong Multi Year Share Price Run? - Sahm
A Look At Amneal Pharmaceuticals (AMRX) Valuation After Launching Its New Glaucoma Generic - Yahoo Finance
FDA sends latest Untitled Letters to Amneal, BioCorRx over brochures, websites - Medical Marketing and Media
Amneal Launches Bimatoprost Ophthalmic Solution, 0.01% - Bitget
AMRX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Volatility Watch: Whats the fair value of Amneal Pharmaceuticals Inc stock2026 Historical Comparison & Proven Capital Preservation Tips - baoquankhu1.vn
Amneal marks Parkinson's Awareness Month, $2M donation - Post Register
Amneal to Report First Quarter 2026 Results on May 1, 2026 - The Manila Times
Amneal Announces $2 Million Donation to Support Patient Access to Essential Medicines During Parkinson’s Awareness Month - The Manila Times
$2M from Amneal targets Parkinson's drug costs for patients - Stock Titan
Trading Recap: Whats the fair value of Amneal Pharmaceuticals Inc stockRate Cut & Low Volatility Stock Recommendations - baoquankhu1.vn
Allspring Global Investments Holdings LLC Grows Stock Position in Amneal Pharmaceuticals, Inc. $AMRX - MarketBeat
Pharma News: Is Amneal Pharmaceuticals Inc in a long term uptrend2026 Geopolitical Influence & Technical Pattern Recognition Alerts - baoquankhu1.vn
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Receives Average Rating of "Buy" from Brokerages - MarketBeat
Amneal Pharmaceuticals Stock: Generic Drug Leader Faces Recall Challenges Amid Sector Growth Opportu - AD HOC NEWS
Tudor Investment Corp ET AL Takes Position in Amneal Pharmaceuticals, Inc. $AMRX - MarketBeat
JPMorgan Chase & Co. Has $7.72 Million Stock Position in Amneal Pharmaceuticals, Inc. $AMRX - MarketBeat
Amneal Pharmaceuticals, Inc. $AMRX Shares Bought by SG Americas Securities LLC - MarketBeat
Amneal Pharmaceuticals (AMRX) price target increased by 13.79% to 16.83 - msn.com
AMRX SEC FilingsAmneal Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Amneal (NYSE: AMRX) Co-CEO receives major performance-based RSU award - Stock Titan
[Form 4/A] Amneal Pharmaceuticals, Inc. Amended Insider Trading Activity - Stock Titan
Suboxone Market Size Forecasts 2026-2033: Analyzing Industry - openPR.com
Major holder Dipan Patel cuts Amneal Pharmaceuticals (AMRX) stake to 5.4% - Stock Titan
Vanguard (AMRX) disaggregates holdings, reports 0 Amneal shares after realignment - Stock Titan
Amneal Pharmaceuticals (NASDAQ: AMRX) posts 2025 growth and seeks backing for board slate - Stock Titan
Amneal Pharmaceuticals, Inc. $AMRX Shares Purchased by Assenagon Asset Management S.A. - MarketBeat
Amneal Pharmaceuticals stock gains momentum as Truist raises target to $17 amid analyst optimism - AD HOC NEWS
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):